Oxycodone hydrochloride
Total Payments
$265,769
Transactions
14
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $249,720 | 5 | 0 |
| 2023 | $1,053 | 1 | 0 |
| 2022 | $14,496 | 6 | 0 |
| 2021 | $500.00 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $251,273 | 8 | 94.5% |
| Consulting Fee | $14,496 | 6 | 5.5% |
Payments by Type
Research
$251,273
8 transactions
General
$14,496
6 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Opioid / BTOD REMS | Hikma Pharmaceuticals USA | $250,773 | 0 |
| Opioid PMR Study | Hikma Pharmaceuticals USA | $500.00 | 0 |
Top Doctors Receiving Payments for Oxycodone hydrochloride
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Loudonville, NY | $265,769 | 14 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $265,769
Product Information
- Type Drug
- Total Payments $265,769
- Total Doctors 0
- Transactions 14
About Oxycodone hydrochloride
Oxycodone hydrochloride is a drug associated with $265,769 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2021 to 2024. In 2024, $249,720 was paid across 5 transactions to 0 doctors.
The most common payment nature for Oxycodone hydrochloride is "Unspecified" ($251,273, 94.5% of total).
Oxycodone hydrochloride is associated with 2 research studies, including "Opioid / BTOD REMS" ($250,773).